Tela Bio Gross Profit vs. Market Capitalization

TELA Stock  USD 2.94  0.07  2.33%   
Considering Tela Bio's profitability and operating efficiency indicators, Tela Bio may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Tela Bio's ability to earn profits and add value for shareholders.
 
Gross Profit  
First Reported
2018-09-30
Previous Quarter
11.1 M
Current Value
12.9 M
Quarterly Volatility
3.7 M
 
Covid
At present, Tela Bio's Days Sales Outstanding is projected to drop based on the last few years of reporting. The current year's Days Of Sales Outstanding is expected to grow to 65.18, whereas Price To Sales Ratio is forecasted to decline to 2.46. At present, Tela Bio's Accumulated Other Comprehensive Income is projected to increase significantly based on the last few years of reporting. The current year's Net Income Per E B T is expected to grow to 1.20, whereas Net Interest Income is forecasted to decline to (5.3 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.470.6862
Way Down
Very volatile
For Tela Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tela Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tela Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tela Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tela Bio over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tela Bio. If investors know Tela will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tela Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.69)
Revenue Per Share
2.789
Quarterly Revenue Growth
0.259
Return On Assets
(0.41)
Return On Equity
(3.42)
The market value of Tela Bio is measured differently than its book value, which is the value of Tela that is recorded on the company's balance sheet. Investors also form their own opinion of Tela Bio's value that differs from its market value or its book value, called intrinsic value, which is Tela Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tela Bio's market value can be influenced by many factors that don't directly affect Tela Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tela Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tela Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tela Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Tela Bio Market Capitalization vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Tela Bio's current stock value. Our valuation model uses many indicators to compare Tela Bio value to that of its competitors to determine the firm's financial worth.
Tela Bio is rated below average in gross profit category among its peers. It is rated below average in market capitalization category among its peers creating about  4.16  of Market Capitalization per Gross Profit. At present, Tela Bio's Gross Profit is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tela Bio's earnings, one of the primary drivers of an investment's value.

Tela Market Capitalization vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Tela Bio

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
27.85 M
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Tela Bio

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
115.8 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Tela Market Capitalization vs Competition

Tela Bio is rated below average in market capitalization category among its peers. Market capitalization of Health Care industry is at this time estimated at about 11.41 Billion. Tela Bio claims roughly 115.8 Million in market capitalization contributing just under 2% to equities under Health Care industry.
Capitalization  Revenue  Valuation  Total debt  Workforce

Tela Bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Tela Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tela Bio will eventually generate negative long term returns. The profitability progress is the general direction of Tela Bio's change in net profit over the period of time. It can combine multiple indicators of Tela Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income91 K95.5 K
Net Interest Income-5.1 M-5.3 M
Interest Income3.3 M2.6 M
Operating Income-44.1 M-41.9 M
Net Loss-43.8 M-45.9 M
Income Before Tax-46.7 M-49 M
Total Other Income Expense Net-2.6 M-2.7 M
Net Loss-39.9 M-41.9 M
Net Loss-46.7 M-49 M
Income Tax Expense640.1 K608.1 K
Non Operating Income Net Other-1.1 M-1.2 M
Change To NetincomeM5.1 M
Net Loss(2.04)(2.14)
Income Quality 0.88  0.74 
Net Income Per E B T 1.15  1.20 

Tela Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Tela Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tela Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tela Bio's important profitability drivers and their relationship over time.

Use Tela Bio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tela Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tela Bio will appreciate offsetting losses from the drop in the long position's value.

Tela Bio Pair Trading

Tela Bio Pair Trading Analysis

The ability to find closely correlated positions to Tela Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tela Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tela Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tela Bio to buy it.
The correlation of Tela Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tela Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tela Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tela Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Tela Bio position

In addition to having Tela Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Rubber and Plastic Products Thematic Idea Now

Rubber and Plastic Products
Rubber and Plastic Products Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Rubber and Plastic Products theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rubber and Plastic Products Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Tela Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tela Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tela Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tela Bio Stock:
Check out World Market Map.
For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
To fully project Tela Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Tela Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Tela Bio's income statement, its balance sheet, and the statement of cash flows.
Potential Tela Bio investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Tela Bio investors may work on each financial statement separately, they are all related. The changes in Tela Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tela Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.